Market revenue in 2022 | USD 136.4 million |
Market revenue in 2030 | USD 260.7 million |
Growth rate | 8.4% (CAGR from 2022 to 2030) |
Largest segment | Continuous blood glucose monitoring system |
Fastest growing segment | Smart insulin pens |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Smart glucose meter, Continuous blood glucose monitoring system, Smart insulin pens, Smart insulin pumps, Apps |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, Bayer AG, Sanofi SA, DexCom Inc, Insulet Corp, PHC Holdings Corp, B. Braun Medical, Brigade High Income Founders |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital diabetes management market will help companies and investors design strategic landscapes.
Continuous blood glucose monitoring system was the largest segment with a revenue share of 40.76% in 2022. Horizon Databook has segmented the Mexico digital diabetes management market based on smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, apps covering the revenue growth of each sub-segment from 2018 to 2030.
Key market drivers include the increasing incidence of diabetes and the launch of advanced diabetes care devices in the region. According to the International Diabetes Federation, there were approximately 12 million people living with diabetes in 2017, implying a prevalence rate of 14.8%.
Diabetes is the leading cause of death in Mexico; it is responsible for nearly 80,000 deaths per year in the country. Moreover, obesity is one of the main reasons for the high prevalence of diabetes. Technological advancements in diabetes care are likely to propel Mexico’s market over the coming years. Connected digital diabetes apps are increasingly ubiquitous.
Most of the newer apps allow patients to import meter data to their smartphones. The integration of data analytics and AI in diabetes care are expected to further propel the market during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico digital diabetes management market, including forecasts for subscribers. This country databook contains high-level insights into Mexico digital diabetes management market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account